Biotech · Private company · Springfield, IL, US
Revopsis Therapeutics, Inc.
Track this companyFree. Adds Revopsis Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Transformational next generation high affinity trispecific fab protein to address unmet needs in OphthalmologyFiscal year 2025 · $933.5KNIH RePORTER 5R44EY035584-02 · fetched Nov 12, 2026
- Transformational next generation high affinity trispecific fab protein to address unmet needs in OphthalmologyFiscal year 2024 · $933.5KNIH RePORTER 1R44EY035584-01A1 · fetched Nov 12, 2026